Baseline characteristics | Univariate | Multivariate | ||
---|---|---|---|---|
 | P | Odd ritio | 95 % CI | P |
Age, yr | 0.438 | Â | Â | Â |
Gender (male/female) | 0.896 | Â | Â | Â |
BMI (≥24 kg/m2) | <0.001 | 0.4 | 0.2–0.8 | 0.013 |
Baseline ALT (IU/L) | Â | Â | Â | 0.004 |
ALT < 80 | 0.003 | 1 | 1 | Â |
80 ≤ ALT < 200 | 0.995 | 1.1 | 0.6–2.0 | 0.83 |
ALT ≥ 200 | 0.002 | 2.5 | 1.3–4.8 | 0.005 |
Baseline HBV DNA(log10copies/ml) | Â | Â | Â | <0.01 |
HBV DAN < 7 | <0.001 | 1 | 1 | Â |
7 ≤ HBV DNA < 9 | <0.001 | 2.8 | 1.4–5.6 | 0.003 |
HBV DNA ≥ 9 | <0.001 | 0.8 | 0.3–2.0 | 0.773 |
Time of undetectable HBV DNA | Â | Â | Â | <0.01 |
≤24 weeks | <0.001 | 3.2 | 1.9–5.5 | <0.001 |
24 < HBV DNA ≤ 48 weeks | <0.001 | 1.3 | 0.6–2.9 | 0.485 |
>48 weeks | 0.385 | 1 | 1 | Â |
Time of Normalization ALT | Â | Â | Â | Â |
≤12 weeks | 0.346 |  |  |  |
12 < ALT ≤ 24 weeks | 0.018 |  |  |  |
>24 weeks | 0.007 | 1 | 1 | Â |